Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-03

Clinical Trial Update: Procarbazine and Lomustine in Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating the combination of procarbazine and lomustine for recurrent glioblastoma. The update does not provide trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lomustine (Lomustine)
  • Procarbazine (procarbazine)

Snippet

Sponsor: Incheon St.Mary's Hospital | Conditions: Recurrent Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN